# Early Vascular Adjustments During Hypertensive Pregnancy

Study · id `cardio:ct-nct02531490` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02531490](<https://clinicaltrials.gov/study/NCT02531490>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT02531490

Browse, organ or system: Blood vessels  
Browse, condition area: High blood pressure  

## In plain language

A phase 4 trial registered on ClinicalTrials.gov. The registry status is unknown. It plans to enroll 368 participants.

## Technical summary

Registry record NCT02531490. Randomized; no masking; primary purpose prevention. Start 2015-01-01 (actual); primary completion 2023-02 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; no masking; primary purpose prevention
- Phase: Phase 4
- Enrolled: 368 participants (planned count; ClinicalTrials.gov record NCT02531490, source copy `cardio:ctgov-nct02531490-2021-03-24`, retrieved 2026-10-26)
- Started: 2015-01-01 (actual) (ClinicalTrials.gov record NCT02531490, source copy `cardio:ctgov-nct02531490-2021-03-24`, retrieved 2026-10-26)
- Primary completion: 2023-02 (anticipated) (ClinicalTrials.gov record NCT02531490, source copy `cardio:ctgov-nct02531490-2021-03-24`, retrieved 2026-10-26)
- Completion: 2023-04 (anticipated) (ClinicalTrials.gov record NCT02531490, source copy `cardio:ctgov-nct02531490-2021-03-24`, retrieved 2026-10-26)
- Countries: Netherlands (ClinicalTrials.gov record NCT02531490, source copy `cardio:ctgov-nct02531490-2021-03-24`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "UNKNOWN" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02531490-2021-03-24`, retrieved 2026-10-26)

## The registry's words

- Brief title: Early Vascular Adjustments During Hypertensive Pregnancy
- Acronym: EVA
- Condition: Hypertension, Pregnancy-Induced
- Condition: Pre-Eclampsia
- Intervention (Drug): Labetalol
- Intervention (Drug): Nifedipine
- Intervention (Drug): Methyldopa
- Lead sponsor: Maastricht University Medical Center
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Hypertension (high blood pressure) (`core:hypertension`)
- Registry intervention name matches this record: Nifedipine (`cardio:nifedipine`)
- Registry lists this organization as the lead sponsor: Maastricht University Medical Center (`cardio:org-maastricht-university-medical-center`)

## Provenance

Content hash: 240faf16fc9c17b9724f2a1d5f74814c2a4a2193940f31a385dd389a46827dab
Last substantive edit: 2026-11-18
Evidence last checked: Not recorded
